Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4587)
All Articles published online
|
Mar 14, 2005 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Österreicher C, Tulassay Z, Molnar T, Reinisch W, Papp J, Mozsik G, Group HIS, Ferenci P. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn’s disease: Phenotype-genotype correlations. World J Gastroenterol 2005; 11(10): 1489-1495 [PMID: 15770725 DOI: 10.3748/wjg.v11.i10.1489] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i10/1489.htm |
| Number | Citing Articles |
| 1 |
J. Lamoril, J.-C. Deybach, P. Bouizegarène. Maladie de Crohn et génétique: connaissances actuelles. Immuno-analyse & Biologie Spécialisée 2007; 22(3): 137 doi: 10.1016/j.immbio.2007.01.002
|
| 2 |
Nahla Azzam, Howaida Nounou, Othman Alharbi, Abedulrahman Aljebreen, Manal Shalaby. CARD15/NOD2, CD14 and Toll-like 4 Receptor Gene Polymorphisms in Saudi Patients with Crohn’s Disease. International Journal of Molecular Sciences 2012; 13(4): 4268 doi: 10.3390/ijms13044268
|
| 3 |
T. Molnar, P. Hofner, F. Nagy, P.L. Lakatos, S. Fischer, L. Lakatos, A. Kovacs, I. Altorjay, M. Papp, K. Palatka, P. Demeter, Z. Tulassay, T. Nyari, P. Miheller, J. Papp, Y. Mandi, J. Lonovics. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. Digestive and Liver Disease 2007; 39(12): 1064 doi: 10.1016/j.dld.2007.09.003
|
| 4 |
Vito Annese, Anna Latiano, Orazio Palmieri, Angelo Andriulli. Dissecting genetic predisposition to inflammatory bowel disease: current progress and prospective application. Expert Review of Clinical Immunology 2007; 3(3): 287 doi: 10.1586/1744666X.3.3.287
|
| 5 |
Paul Henderson, Johan E. van Limbergen, David C. Wilson, Jack Satsangi, Richard K. Russell. Genetics of childhood-onset inflammatory bowel disease. Inflammatory Bowel Diseases 2011; 17(1): 346 doi: 10.1002/ibd.21283
|
| 6 |
Philippe Goyette, Catherine Labbé, Truc T. Trinh, Ramnik J. Xavier, John D. Rioux. Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine. Annals of Medicine 2007; 39(3): 177 doi: 10.1080/07853890701197615
|
| 7 |
Peter Laszlo Lakatos, Simon Fischer, Laszlo Lakatos, Istvan Gal, Janos Papp. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”. World Journal of Gastroenterology 2006; 12(12): 1829-1841 doi: 10.3748/wjg.v12.i12.1829
|
| 8 |
Pal Miheller, Lajos S Kiss, Mark Juhasz, Michael Mandel, Peter L Lakatos. Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Review of Clinical Immunology 2013; 9(1): 65 doi: 10.1586/eci.12.86
|
| 9 |
Lene Riis, Ida Vind, Severine Vermeire, Frank Wolters, Kostas Katsanos, Patrizia Politi, João Freitas, Ioannis A. Mouzas, Colm OʼMorain, Victor Ruiz-Ochoa, Selwyn Odes, Vibeke Binder, Pia Munkholm, Bjrn Moum, Reinhold Stockbrügger, Ebbe Langholz. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflammatory Bowel Diseases 2007; 13(1): 24 doi: 10.1002/ibd.20047
|
| 10 |
Hua-Min Zhang, Shuo Yuan, Huan Meng, Xiao-Ting Hou, Jiao Li, Jia-Chen Xue, You Li, Qi Wang, Ji-Xing Nan, Xue-Jun Jin, Qing-Gao Zhang. Stem Cell-Based Therapies for Inflammatory Bowel Disease. International Journal of Molecular Sciences 2022; 23(15): 8494 doi: 10.3390/ijms23158494
|
| 11 |
Ravi Verma, Vineet Ahuja, Jaishree Paul. Frequency of single nucleotide polymorphisms in NOD1gene of ulcerative colitis patients: a case-control study in the Indian population. BMC Medical Genetics 2009; 10(1) doi: 10.1186/1471-2350-10-82
|
| 12 |
Kathy King, Mohammed F. Sheikh, Andrew P. Cuthbert, Sheila A. Fisher, Clive M. Onnie, Muddassar M. Mirza, Reenal C. Pattni, Jeremy Sanderson, Alastair Forbes, John Mansfield, Cathryn M. Lewis, Roland G. Roberts, Christopher G. Mathew. Mutation, selection, and evolution of the Crohn disease susceptibility geneCARD15. Human Mutation 2006; 27(1): 44 doi: 10.1002/humu.20264
|
| 13 |
Qingping Yao, Melissa Piliang, Katina Nicolacakis, Andrea Arrossi. Granulomatous Pneumonitis Associated with Adult-Onset Blau-like Syndrome. American Journal of Respiratory and Critical Care Medicine 2012; 186(5): 465 doi: 10.1164/ajrccm.186.5.465
|
| 14 |
Byong Duk Ye, Suk-Kyun Yang, Kyuyoung Song, Dong-Hoon Yang, Soon Man Yoon, Kyung Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim. Association of Toll-Like Receptor Gene with Crohn's Disease in Koreans. The Korean Journal of Gastroenterology 2009; 54(6): 377 doi: 10.4166/kjg.2009.54.6.377
|
| 15 |
R. Mucha, M.R. Bhide, E.B. Chakurkar, M. Novak, I. Mikula. Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle. Veterinary Immunology and Immunopathology 2009; 128(4): 381 doi: 10.1016/j.vetimm.2008.12.007
|
| 16 |
Ivan Mikula, Mangesh Bhide, Silvia Pastorekova, Ivan Mikula. Characterization of ovine TLR7 and TLR8 protein coding regions, detection of mutations and Maedi Visna virus infection. Veterinary Immunology and Immunopathology 2010; 138(1-2): 51 doi: 10.1016/j.vetimm.2010.06.015
|
| 17 |
Mária Papp. Possible pathogenetic role of vascular, immunological and genetic factors in certain gastoenterological disorders. Orvosi Hetilap 2008; 149(48): 2269 doi: 10.1556/oh.2008.28463
|
| 18 |
Judy H Cho. Inflammatory bowel disease: Genetic and epidemiologic considerations. World Journal of Gastroenterology 2008; 14(3): 338-347 doi: 10.3748/wjg.14.338
|
| 19 |
Satish Kumar, Subodh Kumar, Ran Vir Singh, Anuj Chauhan, Amit Kumar, Sourabh Sulabh, Jaya Bharati, Shoor Vir Singh. Genetic association of polymorphisms in bovine TLR2 and TLR4 genes with Mycobacterium avium subspecies paratuberculosis infection in Indian cattle population. Veterinary Research Communications 2019; 43(2): 105 doi: 10.1007/s11259-019-09750-2
|
| 20 |
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review. Health Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
|
| 21 |
F Lanzarotto, A Akbar, S Ghosh. Does innate immune response defect underlie inflammatory bowel disease in the Asian population?. Postgraduate Medical Journal 2005; 81(958): 483 doi: 10.1136/pgmj.2005.036590
|
| 22 |
Judy Cho. Genetic advances in inflammatory bowel disease. Current Treatment Options in Gastroenterology 2006; 9(3): 191 doi: 10.1007/s11938-006-0038-z
|
| 23 |
Brian L. Browning, Claudia Huebner, Ivonne Petermann, Richard B Gearry, Murray L. Barclay, Andrew N. Shelling, Lynnette R. Ferguson. Has Toll-Like Receptor 4 Been Prematurely Dismissed as an Inflammatory Bowel Disease Gene? Association Study Combined With Meta-Analysis Shows Strong Evidence for Association. The American Journal of Gastroenterology 2007; 102(11): 2504 doi: 10.1111/j.1572-0241.2007.01463.x
|
| 24 |
Kathryn T. Chen, Madhu S. Malo, Angela K. Moss, Skye Zeller, Paul Johnson, Farzad Ebrahimi, Golam Mostafa, Sayeda N. Alam, Sundaram Ramasamy, H. Shaw Warren, Elizabeth L. Hohmann, Richard A. Hodin. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 299(2): G467 doi: 10.1152/ajpgi.00364.2009
|
| 25 |
Péter Reismann. Study of the Toll-like receptor 4 gene polymorphisms in diseases presenting with subclinical and chronic inflammation. Orvosi Hetilap 2011; 152(46): 1855 doi: 10.1556/OH.2011.29243
|
| 26 |
Peter Laszlo Lakatos, Erika Hitre, Ferenc Szalay, Kerstin Zinober, Peter Fuszek, Laszlo Lakatos, Simon Fischer, Janos Osztovits, Orsolya Gemela, Gabor Veres, Janos Papp, Peter Ferenci. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-54
|
| 27 |
Jeremy Adler, Sujal C Rangwalla, Ben A Dwamena, Peter DR Higgins. The Prognostic Power of the NOD2 Genotype for Complicated Crohn's Disease: A Meta-Analysis. American Journal of Gastroenterology 2011; 106(4): 699 doi: 10.1038/ajg.2011.19
|
| 28 |
Péter Reismann, Károly Rácz, Zsolt Tulassay. Polymorphisms of the Toll-like receptor 4 gene and their potential role in infectious diseases and chronic inflammatory disorders. Orvosi Hetilap 2008; 149(38): 1791 doi: 10.1556/oh.2008.28452
|
| 29 |
Judy H. Cho, Clara Abraham. Inflammatory Bowel Disease Genetics: Nod2. Annual Review of Medicine 2007; 58(1): 401 doi: 10.1146/annurev.med.58.061705.145024
|
| 30 |
Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Morten H. Vatn, Bjørn Moum. Are There Any Differences in Phenotype or Disease Course Between Familial and Sporadic Cases of Inflammatory Bowel Disease? Results of a Population-Based Follow-Up Study. The American Journal of Gastroenterology 2007; 102(9): 1955 doi: 10.1111/j.1572-0241.2007.01368.x
|
| 31 |
Marco Daperno, Fabiana Castiglione, Lissy de Ridder, Iris Dotan, Martti Färkkilä, Jon Florholmen, Gerald Fraser, Walter Fries, Xavier Hebuterne, Peter Laszlo Lakatos, Julián Panés, Jordi Rimola, Edouard Louis. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2011; 5(5): 484 doi: 10.1016/j.crohns.2011.07.003
|
| 32 |
Ivonne Petermann, Claudia Huebner, Brian L. Browning, Richard B. Gearry, Murray L. Barclay, Martin Kennedy, Rebecca Roberts, Andrew N. Shelling, Martin Philpott, Dug Yeo Han, Lynnette R. Ferguson. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Human Immunology 2009; 70(6): 440 doi: 10.1016/j.humimm.2009.03.002
|
| 33 |
Georgina L. Hold, Indrani Mukhopadhya, Tom P. Monie. Innate Immune Sensors and Gastrointestinal Bacterial Infections. Clinical and Developmental Immunology 2011; 2011: 1 doi: 10.1155/2011/579650
|
| 34 |
B. S. Sharma, M. K. Abo‐Ismail, F. S. Schenkel, Q. You, C. P. Verschoor, S. D. Pant, N. A. Karrow. Association of TLR4 polymorphisms with Mycobacterium avium subspecies paratuberculosis infection status in Canadian Holsteins. Animal Genetics 2015; 46(5): 560 doi: 10.1111/age.12333
|
| 35 |
P.L. Lakatos, T. Szamosi, A. Szilvasi, E. Molnar, L. Lakatos, A. Kovacs, T. Molnar, I. Altorjay, M. Papp, Z. Tulassay, P. Miheller, J. Papp, A. Tordai, H. Andrikovics. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Digestive and Liver Disease 2008; 40(11): 867 doi: 10.1016/j.dld.2008.03.022
|
| 36 |
Anton G. Kutikhin. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Human Immunology 2011; 72(10): 955 doi: 10.1016/j.humimm.2011.06.003
|
| 37 |
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scandinavian Journal of Gastroenterology 2007; 42(6): 726 doi: 10.1080/00365520601101559
|
| 38 |
O. Hradsky, M. Lenicek, P. Dusatkova, J. Bronsky, J. Nevoral, V. Valtrova, R. Kotalova, P. Szitanyi, R. Petro, V. Starzykova, M. Bortlik, L. Vitek, M. Lukas, O. Cinek. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn’s disease in the Czech population: high frequency of the CARD15 1007fs. Tissue Antigens 2008; 71(6): 538 doi: 10.1111/j.1399-0039.2008.01047.x
|
| 39 |
Patricia Cristofaro, Steven M Opal. Role of Toll-Like Receptors in Infection and Immunity. Drugs 2006; 66(1): 15 doi: 10.2165/00003495-200666010-00002
|
| 40 |
S. VERMEIRE. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2006; 24(s3): 2 doi: 10.1111/j.1365-2036.2006.03052.x
|
| 41 |
Séverine Vermeire, Dermot P. McGovern, Gert Van Assche, Paul Rutgeerts. Inflammatory Bowel Disease. 2010; : 16 doi: 10.1002/9781444318418.ch4
|
| 42 |
Inés Omrane, Amel Mezlini, Olfa Baroudi, Nejla Stambouli, Karim Bougatef, Hager Ayari, Imen Medimegh, Hassen Bouzaienne, Nancy Uhrhammer, Yves-Jean Bignon, Amel Benammar-Elgaaied, Raja Marrakchi. 3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer. Medical Oncology 2014; 31(5) doi: 10.1007/s12032-014-0954-z
|
| 43 |
Yang Cheng, Yun Zhu, Xiuping Huang, Wei Zhang, Zelong Han, Side Liu, David L Boone. Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis. PLOS ONE 2015; 10(5): e0126803 doi: 10.1371/journal.pone.0126803
|
| 44 |
Katherine Anne Siminovitch. Advances in the molecular dissection of inflammatory bowel disease. Seminars in Immunology 2006; 18(4): 244 doi: 10.1016/j.smim.2006.03.012
|
| 45 |
Siew C. Ng. Epidemiology of inflammatory bowel disease: Focus on Asia. Best Practice & Research Clinical Gastroenterology 2014; 28(3): 363 doi: 10.1016/j.bpg.2014.04.003
|
| 46 |
L Lakatos, P L Lakatos. Management of inflammatory bowel diseases in Eastern Europe. Postgraduate Medical Journal 2006; 82(966): 270 doi: 10.1136/pgmj.2005.043901
|
| 47 |
Bram Verstockt, Isabelle Cleynen. Genetic Influences on the Development of Fibrosis in Crohn’s Disease. Frontiers in Medicine 2016; 3 doi: 10.3389/fmed.2016.00024
|
| 48 |
Lilia Zouiten-Mekki, Maher Kharrat, Sami Karoui, Mariem Serghimi, Monia Fekih, Samira Matri, Lamia Kallel, Jalel Boubaker, Azza Filali, Habiba Chaabouni. Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: genotype-phenotype correlation. BMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-62
|
| 49 |
S Vermeire, P Rutgeerts. Current status of genetics research in inflammatory bowel disease. Genes & Immunity 2005; 6(8): 637 doi: 10.1038/sj.gene.6364257
|
| 50 |
Godfrey E. Etokebe, Jelena Knežević, Branka Petričević, Jasminka Pavelić, Damir Vrbanec, Zlatko Dembić. Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case–Control Study with Breast Cancer. Genetic Testing and Molecular Biomarkers 2009; 13(6): 729 doi: 10.1089/gtmb.2009.0045
|
| 51 |
Frans van der Heide, Ilja M Nolte, Jan H Kleibeuker, Cisca Wijmenga, Gerard Dijkstra, Rinse K Weersma. Differences in Genetic Background Between Active Smokers, Passive Smokers, and Non-Smokers With Crohn's Disease. American Journal of Gastroenterology 2010; 105(5): 1165 doi: 10.1038/ajg.2009.659
|
| 52 |
S. M. Opal, P. A. Cristofaro. Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery. Update in Intensive Care and Emergency Medicine 2007; 44: 35 doi: 10.1007/3-540-30328-6_3
|
| 53 |
Tamas Jilling, Dyan Simon, Jing Lu, Fan Jing Meng, Dan Li, Robert Schy, Richard B. Thomson, Antoine Soliman, Moshe Arditi, Michael S. Caplan. The Roles of Bacteria and TLR4 in Rat and Murine Models of Necrotizing Enterocolitis. The Journal of Immunology 2006; 177(5): 3273 doi: 10.4049/jimmunol.177.5.3273
|
| 54 |
A Trejo-de la O, P Hernández-Sancén, C Maldonado-Bernal. Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer. Genes & Immunity 2014; 15(4): 199 doi: 10.1038/gene.2014.10
|
| 55 |
Sang Mok Lee, Eon Chul Han, Seung-Bum Ryoo, Heung-Kwon Oh, Eun Kyung Choe, Sang Hui Moon, Joo Sung Kim, Hyun Chae Jung, Kyu Joo Park. Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea. Annals of Coloproctology 2015; 31(4): 144 doi: 10.3393/ac.2015.31.4.144
|
| 56 |
Maria Papp, Istvan Altorjay, Gary L. Norman, Zakera Shums, Karoly Palatka, Zsuzsanna Vitalis, Ildiko Foldi, Gabriella Lakos, Judit Tumpek, Miklos L. Udvardy, Jolan Harsfalvi, Simon Fischer, Laszlo Lakatos, Agota Kovacs, Laszlo Bene, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gabor Veres, Janos Papp, Peter Laszlo Lakatos. Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflammatory Bowel Diseases 2007; 13(8): 984 doi: 10.1002/ibd.20146
|
| 57 |
Maarit Lappalainen, Paulina Paavola-Sakki, Leena Halme, Ulla Turunen, Martti Färkkilä, Heikki Repo, Kimmo Kontula. Novel CARD15/NOD2 mutations in Finnish patients with Crohnʼs disease and their relation to phenotypic variation in vitro and in vivo. Inflammatory Bowel Diseases 2008; 14(2): 176 doi: 10.1002/ibd.20287
|
| 58 |
Norio Matsushima, Shintaro Takatsuka, Hiroki Miyashita, Robert H. Kretsinger. Leucine Rich Repeat Proteins: Sequences, Mutations, Structures and Diseases. Protein & Peptide Letters 2019; 26(2): 108 doi: 10.2174/0929866526666181208170027
|
| 59 |
Jiwon Hong, Euphemia Leung, Alan G Fraser, Tony R Merriman, Prakash Vishnu, Geoffrey W Krissansen. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. Journal of Gastroenterology and Hepatology 2007; 22(11): 1760 doi: 10.1111/j.1440-1746.2006.04727.x
|
| 60 |
Timothy J. Wilson, Mariana Jobim, Luiz Fernando Jobim, Pamela Portela, Patrícia H. Salim, Mário A. Rosito, Daniel C. Damin, Cristina Flores, Alessandra Peres, Marta Brenner Machado, José Artur Bogo Chies, Gilberto Schwartsmann, Rafael Roesler. Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis. Human Immunology 2010; 71(3): 293 doi: 10.1016/j.humimm.2009.12.006
|
| 61 |
Ágnes Katalin Kocsis, Péter Laszló Lakatos, Ferenc Somogyvári, Peter Fuszek, János Papp, Simon Fischer, Tamás Szamosi, Laszlo Lakatos, Ágota Kovacs, Peter Hofner, Yvette Mándi. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scandinavian Journal of Gastroenterology 2008; 43(3): 299 doi: 10.1080/00365520701682615
|
| 62 |
Szilard Poliska, Andras Penyige, Peter Laszlo Lakatos, Maria Papp, Karoly Palatka, Laszlo Lakatos, Tamas Molnar, Laszlo Nagy. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort. Inflammatory Bowel Diseases 2012; 18(3): 472 doi: 10.1002/ibd.21798
|
| 63 |
Bram Verstockt, Sare Verstockt, Isabelle Cleynen. Fibrostenotic Inflammatory Bowel Disease. 2018; : 13 doi: 10.1007/978-3-319-90578-5_3
|
| 64 |
Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Gwo-Tzer Ho, Ian D. Arnott, David C. Wilson, Jack Satsangi. Genetics of the innate immune response in inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(3): 338 doi: 10.1002/ibd.20096
|
| 65 |
Anton G. Kutikhin, Arseniy E. Yuzhalin. Genomics of Pattern Recognition Receptors. 2013; : 123 doi: 10.1007/978-3-0348-0688-6_7
|
| 66 |
Daniel R Gaya, Richard K Russell, Elaine R Nimmo, Jack Satsangi. New genes in inflammatory bowel disease: lessons for complex diseases?. The Lancet 2006; 367(9518): 1271 doi: 10.1016/S0140-6736(06)68345-1
|
| 67 |
Lajos Sándor Kiss, Péter László Lakatos. Prediction of the disease course in inflammatory bowel diseases. Orvosi Hetilap 2010; 151(8): 293 doi: 10.1556/oh.2010.28813
|
| 68 |
Fabian Schnitzler, Matthias Friedrich, Marianne Angelberger, Julia Diegelmann, Johannes Stallhofer, Christiane Wolf, Joel Dütschler, Samuel Truniger, Torsten Olszak, Florian Beigel, Cornelia Tillack, Peter Lohse, Stephan Brand, Cinzia Ciccacci. Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery. PLOS ONE 2020; 15(7): e0236421 doi: 10.1371/journal.pone.0236421
|
| 69 |
Lynnette R. Ferguson, Andrew N. Shelling, Brian L. Browning, Claudia Huebner, Ivonne Petermann. Genes, diet and inflammatory bowel disease. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2007; 622(1-2): 70 doi: 10.1016/j.mrfmmm.2007.05.011
|
| 70 |
Georgia E. Hume, Elizabeth V. Fowler, James Doecke, Lisa A. Simms, Ning Huang, Orazio Palmieri, Lyn R. Griffiths, Timothy H.J. Florin, Vito Annese, Graham L. Radford-Smith. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohnʼs disease in an Australian population. Inflammatory Bowel Diseases 2008; 14(5): 585 doi: 10.1002/ibd.20362
|
| 71 |
David Walsh, Joanna McCarthy, Caitriona O’Driscoll, Silvia Melgar. Pattern recognition receptors—Molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine & Growth Factor Reviews 2013; 24(2): 91 doi: 10.1016/j.cytogfr.2012.09.003
|
| 72 |
Naoual El Menyiy, Aicha El Allam, Sara Aboulaghras, Imane Jaouadi, Saad Bakrim, Nasreddine El Omari, Mohammad Ali Shariati, Alevtin Miftakhutdinov, Polrat Wilairatana, Mohammad S. Mubarak, Abdelhakim Bouyahya. Inflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds. Biomedicine & Pharmacotherapy 2022; 151: 113158 doi: 10.1016/j.biopha.2022.113158
|
| 73 |
M. Ellen Kuenzig, Jeff Yim, Stephanie Coward, Bertus Eksteen, Cynthia H. Seow, Cheryl Barnabe, Herman W. Barkema, Mark S. Silverberg, Peter L. Lakatos, Paul L. Beck, Richard Fedorak, Levinus A. Dieleman, Karen Madsen, Remo Panaccione, Subrata Ghosh, Gilaad G. Kaplan. The NOD2 -Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study. EBioMedicine 2017; 21: 188 doi: 10.1016/j.ebiom.2017.06.012
|
| 74 |
Julia Seiderer, Fabian Schnitzler, Stephan Brand, Tanja Staudinger, Simone Pfennig, Karin Herrmann, Katrin Hofbauer, Julia Dambacher, Cornelia Tillack, Michael Sackmann, Burkhard Göke, Peter Lohse, Thomas Ochsenkühn. Homozygosity for theCARD15frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scandinavian Journal of Gastroenterology 2006; 41(12): 1421 doi: 10.1080/00365520600703900
|
| 75 |
P L De Jager, D Franchimont, A Waliszewska, A Bitton, A Cohen, D Langelier, J Belaiche, S Vermeire, L Farwell, A Goris, C Libioulle, N Jani, T Dassopoulos, G P Bromfield, B Dubois, J H Cho, S R Brant, R H Duerr, H Yang, J I Rotter, M S Silverberg, A H Steinhart, M J Daly, D K Podolsky, E Louis, D A Hafler, J D Rioux. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes & Immunity 2007; 8(5): 387 doi: 10.1038/sj.gene.6364398
|
| 76 |
R. K. WEERSMA, H. M. VAN DULLEMEN, G. VAN DER STEEGE, I. M. NOLTE, J. H. KLEIBEUKER, G. DIJKSTRA. Review article: inflammatory bowel disease and genetics. Alimentary Pharmacology & Therapeutics 2007; 26(s2): 57 doi: 10.1111/j.1365-2036.2007.03476.x
|
| 77 |
Mark Silverberg, Sarah O’Donnell. Inflammatory Bowel Disease. Clinical Gastroenterology 2017; : 29 doi: 10.1007/978-3-319-53763-4_3
|
| 78 |
Si Ming Man, Nadeem O. Kaakoush, Hazel M. Mitchell. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nature Reviews Gastroenterology & Hepatology 2011; 8(3): 152 doi: 10.1038/nrgastro.2011.3
|
| 79 |
P. L. Lakatos. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 43 doi: 10.1007/978-1-4020-8767-7_6
|
| 80 |
Nezha Senhaji, Brehima Diakité, Nadia Serbati, Younes Zaid, Wafaa Badre, Sellama Nadifi. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0206-x
|
| 81 |
Graham Radford-Smith, Nirmala Pandeya. Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease-Are we there yet?. World Journal of Gastroenterology 2006; 12(44): 7097-7103 doi: 10.3748/wjg.v12.i44.7097
|
| 82 |
Marian C Aldhous, J Satsangi. The impact of smoking in Crohn's disease: no smoke without fire. Frontline Gastroenterology 2010; 1(3): 156 doi: 10.1136/fg.2010.001487
|
| 83 |
Lissy de Ridder, Rinse K. Weersma, Gerard Dijkstra, Gerrit van der Steege, Marc A. Benninga, Ilja M. Nolte, Jan A.J. M. Taminiau, Daniël W. Hommes, Pieter C. F. Stokkers. Genetic susceptibility has a more important role in pediatric-onset Crohnʼs disease than in adult-onset Crohnʼs disease. Inflammatory Bowel Diseases 2007; 13(9): 1083 doi: 10.1002/ibd.20171
|
| 84 |
S Pabst, G Baumgarten, A Stremmel, M Lennarz, P Knüfermann, A Gillissen, H Vetter, C Grohé. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clinical and Experimental Immunology 2006; 143(3): 420 doi: 10.1111/j.1365-2249.2006.03008.x
|
| 85 |
L. Kallel, N. Nijaa, L. Ben Fatma, L. Rais, N. Ben Mustapha, S. Matri, S. Karoui, M. Fekih, J. Boubaker, F. Ben Moussa, A. Filali. Familial cases of glomerulonephritis complicating Crohn's disease. Journal of Crohn's and Colitis 2009; 3(2): 125 doi: 10.1016/j.crohns.2009.01.002
|
| 86 |
E. Ann Misch, Thomas R. Hawn. Toll-like receptor polymorphisms and susceptibility to human disease. Clinical Science 2008; 114(5): 347 doi: 10.1042/CS20070214
|
| 87 |
Maria Papp, Peter Laszlo Lakatos, Karoly Palatka, Ildiko Foldi, Miklos Udvardy, Jolan Harsfalvi, Istvan Tornai, Zsuzsanna Vitalis, Tamas Dinya, Agota Kovacs, Tamas Molnar, Pal Demeter, Janos Papp, Laszlo Lakatos, Istvan Altorjay. Haptoglobin Polymorphisms Are Associated with Crohn’s Disease, Disease Behavior, and Extraintestinal Manifestations in Hungarian Patients. Digestive Diseases and Sciences 2007; 52(5): 1279 doi: 10.1007/s10620-006-9615-1
|
| 88 |
Jennifer Bailey. Editorial: Factors Promoting Development of Fibrosis in Crohn’s Disease. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00160
|